178 related articles for article (PubMed ID: 8874200)
1. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.
de Vries E; Koene HR; Vossen JM; Gratama JW; von dem Borne AE; Waaijer JL; Haraldsson A; de Haas M; van Tol MJ
Blood; 1996 Oct; 88(8):3022-7. PubMed ID: 8874200
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).
Jawahar S; Moody C; Chan M; Finberg R; Geha R; Chatila T
Clin Exp Immunol; 1996 Mar; 103(3):408-13. PubMed ID: 8608639
[TBL] [Abstract][Full Text] [Related]
3. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
[TBL] [Abstract][Full Text] [Related]
4. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.
Lenart M; Trzyna E; Rutkowska M; Bukowska-Strakova K; Szaflarska A; Pituch-Noworolska A; Szczepanik A; Zembala M; Siedlar M
Int J Mol Med; 2010 Sep; 26(3):435-42. PubMed ID: 20664961
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.
Grier JT; Forbes LR; Monaco-Shawver L; Oshinsky J; Atkinson TP; Moody C; Pandey R; Campbell KS; Orange JS
J Clin Invest; 2012 Oct; 122(10):3769-80. PubMed ID: 23006327
[TBL] [Abstract][Full Text] [Related]
6. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
Congy-Jolivet N; Bolzec A; Ternant D; Ohresser M; Watier H; Thibault G
Cancer Res; 2008 Feb; 68(4):976-80. PubMed ID: 18281470
[TBL] [Abstract][Full Text] [Related]
7. Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells.
Uciechowski P; Werfel T; Leo R; Gessner JE; Schubert J; Schmidt RE
Immunobiology; 1992 Jun; 185(1):28-40. PubMed ID: 1398740
[TBL] [Abstract][Full Text] [Related]
8. Proliferative and cytotoxic capabilities of CD16+CD56- and CD16+/-CD56+ natural killer cells.
Søndergaard SR; Ullum H; Pedersen BK
APMIS; 2000 Dec; 108(12):831-7. PubMed ID: 11252817
[TBL] [Abstract][Full Text] [Related]
9. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
10. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype.
Koene HR; Kleijer M; Algra J; Roos D; von dem Borne AE; de Haas M
Blood; 1997 Aug; 90(3):1109-14. PubMed ID: 9242542
[TBL] [Abstract][Full Text] [Related]
11. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
12. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
13. Activation of cloned human natural killer cells via Fc gamma RIII.
Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
[TBL] [Abstract][Full Text] [Related]
14. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells.
Cone JC; Lu Y; Trevillyan JM; Bjorndahl JM; Phillips CA
Eur J Immunol; 1993 Oct; 23(10):2488-97. PubMed ID: 8405050
[TBL] [Abstract][Full Text] [Related]
15. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
[TBL] [Abstract][Full Text] [Related]
16. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
17. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
18. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
Lanier LL; Kipps TJ; Phillips JH
J Exp Med; 1985 Dec; 162(6):2089-106. PubMed ID: 2415663
[TBL] [Abstract][Full Text] [Related]
19. Relevance of Fc gamma RIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients.
Sugita N; Yamamoto K; Kobayashi T; Van Der Pol W; Horigome T; Yoshie H; Van De Winkel JG; Hara K
Clin Exp Immunol; 1999 Aug; 117(2):350-4. PubMed ID: 10444269
[TBL] [Abstract][Full Text] [Related]
20. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
